stanozolol has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Brasil, GA; da Silva, CL; de Andrade, TU; de Lima, EM; de Souza Andrade Moraes, F; do Nascimento, AM; Dubois Filho, DG; Falsoni, RMP; Haguihara, SCGC | 1 |
| Barone, Y; Matrisciano, F; Modafferi, AM; Nicoletti, F; Pinna, G; Scaccianoce, S; Togna, GI | 1 |
| Dou, J; Du, ML; Huang, TT; Li, YH; Luo, HB; Ma, HM; Zhu, SY | 1 |
| Ackermann, M; Konerding, MA; Wellmann, A; Wolloscheck, T; Ziebart, T | 1 |
| Borghetti, P; Cantoni, AM; Corradi, A; Predieri, PG; Romagnoli, N; Spadari, A | 1 |
6 other study(ies) available for stanozolol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Stanozolol promotes lipid deposition in the aorta through an imbalance in inflammatory cytokines and oxidative status in LDLr knockout mice fed a normal diet.
Topics: Anabolic Agents; Animals; Aorta; Atherosclerosis; Cytokines; Disease Models, Animal; Disease Progression; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Receptors, LDL; Stanozolol | 2019 |
Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
Topics: Anabolic Agents; Androgens; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Clomipramine; Corticosterone; Depressive Disorder; Disease Models, Animal; Hypothalamo-Hypophyseal System; Male; Nandrolone; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Stanozolol; Steroids; Substance-Related Disorders | 2010 |
Stanozolol regulates proliferation of growth plate chondrocytes via activation of ERalpha in GnRHa-treated adolescent rats.
Topics: Animals; Binding Sites; Body Height; Cell Proliferation; Child; Chondrocytes; Disease Models, Animal; Estrogen Receptor alpha; Female; Gonadotropin-Releasing Hormone; Growth Plate; Humans; Male; MAP Kinase Signaling System; Molecular Dynamics Simulation; Phosphorylation; Puberty, Precocious; Rats; Receptors, Androgen; Stanozolol | 2011 |
Impact of single-dose application of TGF-β, copper peptide, stanozolol and ascorbic acid in hydrogel on midline laparatomy wound healing in a diabetic mouse model.
Topics: Animals; Ascorbic Acid; Cicatrix; Copper; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Fibrillar Collagens; Hydrogels; Laparotomy; Mice; Mice, Inbred BALB C; Peptides; Stanozolol; Tensile Strength; Transforming Growth Factor beta; Wound Healing | 2012 |
Effects of intraarticular treatment with stanozolol on synovial membrane and cartilage in an ovine model of osteoarthritis.
Topics: Anabolic Agents; Animals; Cartilage; Disease Models, Animal; Female; Injections, Intra-Articular; Lameness, Animal; Osteoarthritis; Sheep; Sheep Diseases; Stanozolol; Synovial Fluid; Synovial Membrane | 2013 |